Crestwood Advisors Group LLC Bristol Myers Squibb CO Transaction History

Crestwood Advisors Group LLC

$5.07 Billion
Q3 2024

A detailed history of Crestwood Advisors Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 5,857 shares of BMY stock, worth $337,831. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,857

Previous 5,245 11.67%

Holding current value

$337,831

Previous $217,000 39.63%

% of portfolio

0.01%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $24,271 - $31,671	612 Added 11.67%	5,857 $303,000
Q2 2024 Aug 01, 2024	SELL	$40.25 - $52.99 $199,479 - $262,618	-4,956 Reduced 48.58%	5,245 $217,000
Q1 2024 May 08, 2024	BUY	$47.98 - $54.4 $87,323 - $99,008	1,820 Added 21.72%	10,201 $553,000
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $46,589 - $55,593	-961 Reduced 10.29%	8,381 $430,000
Q3 2023 Nov 15, 2023	SELL	$57.89 - $64.73 $22,345 - $24,985	-386 Reduced 3.97%	9,342 $542,000
Q2 2023 Aug 15, 2023	SELL	$63.71 - $70.74 $47,846 - $53,125	-751 Reduced 7.17%	9,728 $622,000
Q1 2023 May 12, 2023	BUY	$65.71 - $74.53 $25,955 - $29,439	395 Added 3.92%	10,479 $726,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $11,847 - $14,028	173 Added 1.75%	10,084 $725,000
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $141 - $83,755	-1,090 Reduced 9.91%	9,911 $705,000
Q2 2022 Jul 07, 2022	BUY	$72.62 - $79.98 $334,778 - $368,707	4,610 Added 72.13%	11,001 $847,000
Q1 2022 Apr 12, 2022	BUY	$61.48 - $73.72 $53,733 - $64,431	874 Added 15.84%	6,391 $467,000
Q4 2021 Feb 15, 2022	BUY	$53.63 - $62.52 $23,650 - $27,571	441 Added 8.69%	5,517 $344,000
Q3 2021 Nov 03, 2021	BUY	$59.17 - $69.31 $24,200 - $28,347	409 Added 8.76%	5,076 $300,000
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $95,960 - $104,501	-1,550 Reduced 24.93%	4,667 $312,000
Q1 2021 Apr 21, 2021	SELL	$59.34 - $66.74 $88,297 - $99,309	-1,488 Reduced 19.31%	6,217 $392,000
Q4 2020 Feb 09, 2021	BUY	$57.74 - $65.43 $165,887 - $187,980	2,873 Added 59.46%	7,705 $478,000
Q3 2020 Oct 06, 2020	SELL	$57.43 - $63.64 $47,092 - $52,184	-820 Reduced 14.51%	4,832 $291,000
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $3,124 - $3,653	-57 Reduced 1.0%	5,652 $332,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $148,433 - $215,708	-3,199 Reduced 35.91%	5,709 $318,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $438,362 - $571,804	8,908 New	8,908 $572,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $259,827 - $308,063	-6,075 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $271,066 - $299,740	6,075 New	6,075 $276,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $167,557 - $208,841	-3,316 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $958 - $1,103	16 Added 0.48%	3,316 $210,000
Q4 2017 Jan 11, 2018	BUY	$59.94 - $65.35 $197,802 - $215,654	3,300	3,300 $202,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestwood Advisors Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crestwood Advisors Group LLC with notifications on news.

Account

Crestwood Advisors Group LLC Bristol Myers Squibb CO Transaction History